MC2R
Adrenocorticotropic hormone receptor
As of the edition of 20 October 2026, MC2R (adrenocorticotropic hormone receptor, UniProt Q01718) has 5 drugs tested at it and 9 companies on the list, 0 on route A and 1 on route B.
Sources: UniProt, ClinicalTrials.gov, ChEMBL, FDA Orange Book and Purple Book, Pharos.
The protein
- UniProt
- Q01718
- How well studied
- Drug target: an approved drug acts on it
- Where it sits in the cell
- At a membrane
- Solved structures
- 2
- Disease areas
- Immune system; Nervous system; Urinary and reproductive; Pregnancy and women's health; Hormones; Skin and connective tissue; Bones, joints and muscles; Eye
- Registered trials of its drugs
- 111
Drugs at this target
| Status | Count |
|---|---|
| Marketed | 3 |
| Active | 1 |
| Withdrawn from market | 1 |
| Total | 5 |
| Drug | Status | Furthest phase | US protection |
|---|---|---|---|
| Corticotropin | Marketed | Phase 4 | none listed |
| Cosyntropin | Marketed | Phase 4 | none listed |
| Atumelnant | Active | Phase 3 | none listed |
| Corticotropin zinc hydroxide | Marketed | No phase stated | none listed |
| Seractide acetate | Withdrawn from market | No phase stated | none listed |
5 of 5 drugs, the most tested first.
Companies at this target
| Where the company stands | Companies |
|---|---|
| Route B | 1 |
| Engaged | 6 |
| Undetermined | 2 |
| Total on the list | 9 |
| Company | Route |
|---|---|
| Pfizer | Route B |
The other 8 companies at MC2R
In the product9 companies in all; 8 are not named here, and no score is.
See the 9 companies at MC2R, ranked, with the facts behind eachRequest access. Nothing is shown until you do.